STOCK TITAN

Liveperson Inc SEC Filings

LPSN NASDAQ

Welcome to our dedicated page for Liveperson SEC filings (Ticker: LPSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The LivePerson Inc (LPSN) SEC filings page on Stock Titan centralizes the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. LivePerson is a Nasdaq-listed software publisher in the information sector, and its filings provide detailed insight into its conversational AI platform, financial performance, capital structure, and governance.

Key filings for LPSN include annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss revenue from hosted services and professional services, trends in customer activity, non-GAAP measures such as adjusted EBITDA and free cash flow, and extensive risk factor disclosures. These reports explain how LivePerson views its position in conversational AI, outline dependencies on partners and platforms, and describe regulatory considerations around data privacy, security, and AI.

Current reports on Form 8-K are especially important for tracking material events. In 2025, LivePerson filed multiple 8-Ks describing a privately negotiated exchange of its 0% Convertible Senior Notes due 2026 for cash, new 10.0% Second Lien Senior Subordinated Secured Notes due 2029, common equity, and Series B Fixed Rate Convertible Perpetual Preferred Stock. Other 8-Ks detail the completion of a strategic refinancing that materially deleveraged the balance sheet, extended debt maturities to December 2029, and captured a significant debt discount, as well as stockholder-approved amendments to the certificate of incorporation, a 1-for-15 reverse stock split, and the conversion of Series B preferred stock into common shares.

Filings also document governance changes, such as the appointments of Ryan L. Vardeman and Nathan “Tripp” Lane to the Board of Directors, along with their compensation and any related-party considerations. Proxy materials, including the definitive proxy statement on Schedule 14A for the 2025 special meeting, provide additional detail on proposals related to authorized share increases and the reverse stock split, voting arrangements with noteholders, and ownership of securities.

On Stock Titan, these documents are updated in near real time from EDGAR and paired with AI-generated summaries that highlight what changed, why it matters, and where to find specifics on topics like debt terms, equity issuance, reverse stock split mechanics, and board appointments. Users can quickly navigate to Forms 10-K, 10-Q, 8-K, and proxy statements, and review insider-related information disclosed in Forms 3 and 4 where applicable. This makes it easier to understand how LivePerson’s regulatory record reflects its strategy, financial condition, and risk profile without reading every page manually.

Rhea-AI Summary

LivePerson, Inc. reported that director Nathan Lane received an equity award on December 10, 2025. He was granted 23,350 restricted stock units (RSUs) under the LivePerson, Inc. 2019 Stock Incentive Plan, each representing a contingent right to receive one share of common stock at a purchase price of $0.00 per share.

The RSUs will fully vest on December 10, 2026, as disclosed, and Lane now beneficially owns 23,350 shares in the form of unvested RSUs held directly following this grant. The transaction is reported as an acquisition of common stock related to director compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

LivePerson, Inc. (LPSN) reported an insider stock sale by its Chief Financial Officer and Chief Operating Officer, John DeNeen Collins. On 11/14/2025, Collins sold 20,000 shares of common stock in an open-market transaction coded "S" for sale. The shares were sold at a weighted average price of $5.1944 per share, with individual trades executed between $5.13 and $5.38.

After this sale, Collins beneficially owns 81,814 shares of LivePerson common stock. This figure reflects the company’s 1-for-15 reverse stock split that took effect on October 13, 2025, and includes 69,571 unvested restricted stock units that remain granted to and held by him.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

LivePerson Inc. (LPSN) reported an insider stock sale by its Chief Executive Officer and director. On 11/14/2025, the reporting person sold 30,000 shares of LivePerson common stock in an open-market transaction coded "S" (sale) at a weighted average price of $5.263 per share, with individual trades executed between $5.11 and $5.475.

After this transaction, the insider beneficially owned 153,749 shares, held directly. This figure reflects the company’s 1-for-15 reverse stock split that took effect on October 13, 2025, and includes 133,333 unvested restricted stock units granted to the insider.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

LivePerson, Inc. (LPSN) filed a Form 3 initial statement of beneficial ownership for a reporting person serving as a director. As of the event date of 11/07/2025, the filing states that no securities are beneficially owned. The form is filed on behalf of the reporting person by Monica L. Greenberg as attorney-in-fact, and indicates it is a single-person filing rather than a joint filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.5%
Tags
insider
-
Rhea-AI Summary

LivePerson (LPSN) appointed Nathan “Tripp” Lane to its Board as a Class II director effective November 7, 2025, with a term expiring at the 2026 Annual Meeting of Stockholders. He was nominated pursuant to the previously announced Exchange Agreement with former holders of the Company’s 0% Senior Convertible Notes due 2026, following the Company’s standard governance review. Committee assignments will be disclosed later. Lane will receive standard annual director fees and benefits and an initial equity grant under the Amended and Restated 2019 Stock Incentive Plan. The Company intends to enter into its standard director indemnification agreement with him.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

LivePerson, Inc. reported Q3 2025 results marked by lower revenue but a swing to net income driven by a debt transaction. Revenue was $60.2 million versus $74.2 million a year ago, with hosted services at $51.2 million and professional services at $9.0 million. Loss from operations was $14.6 million, but a $27.7 million gain on troubled debt restructuring lifted net income to $8.7 million; basic EPS was $0.98.

Cash and cash equivalents were $106.7 million, and senior notes declined to $382.4 million from $527.1 million, reflecting a September 2025 exchange of $341.1 million of 2026 notes for $45.0 million cash, $115.0 million of 10.0% Second Lien Notes due 2029, 3,555,596 common shares, and 26,551 Series B preferred (plus 143,192 additional shares issued September 25). Total equity improved to $(22.1) million from $(67.3) million. Remaining performance obligations were $182.4 million, with 97% expected to be recognized over the next 24 months. A 1‑for‑15 reverse stock split was effected in October 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

LivePerson, Inc. (LPSN) furnished a press release announcing its results of operations and financial condition for the quarter ended September 30, 2025. The release was provided as Exhibit 99.1 to a Form 8-K under Item 2.02.

The company states this information is furnished, not filed under Section 18 of the Exchange Act and will not be incorporated by reference into other filings unless specifically stated. An Inline XBRL cover page was included as Exhibit 104.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.5%
Tags
current report
-
Rhea-AI Summary

LivePerson (LPSN): Initial Form 3 filed by director Ryan L. Vardeman as of 10/14/2025. He reports 44,422 shares of common stock, held indirectly. He also reports indirect ownership of 0% Convertible Senior Notes due 2026 convertible into 3,456 shares at a conversion/exercise price of $1,128.39. The filing notes indirect ownership through Palogic entities and includes a standard disclaimer of beneficial ownership except to the extent of pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

LivePerson, Inc. appointed Ryan L. Vardeman as a Class III director effective October 14, 2025, with a term expiring at the 2027 Annual Meeting of Stockholders. He was nominated pursuant to the previously announced Exchange Agreement with certain former holders of the Company’s 0% Senior Convertible Notes due 2026, following the Company’s standard governance processes.

The Company disclosed under Item 404(a) that Palogic Value Fund, LP—affiliated with Mr. Vardeman—participated as a Noteholder in the exchange and received approximately $1.3 million in cash, approximately $3.3 million principal amount of Second Lien Senior Subordinated Secured Notes due 2029, 1,592,984 shares (or 106,198 post‑reverse‑split) of common stock, and 762 shares of Series B Fixed Rate Convertible Perpetual Preferred Stock. Mr. Vardeman will receive standard director compensation and an initial equity grant under the Amended and Restated 2019 Stock Incentive Plan. A press release announcing the appointment is furnished as Exhibit 99.1.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
current report
Rhea-AI Summary

LivePerson, Inc. stockholders approved a reverse stock split at a Special Meeting, and the Board set a 1-for-15 reverse split to be effective before market open on October 13, 2025. At the Effective Time every 15 issued and outstanding shares will be combined into one share, and the company will proportionately reduce authorized common shares from 300,000,000 to 20,000,000. The Company will adjust outstanding equity awards, warrants, convertible notes and plan share pools in proportion to the split terms; par value remains unchanged. No fractional shares will be issued; cash will be paid in lieu of fractional shares. Trading is expected to resume on Nasdaq under the existing symbol LPSN with a new CUSIP of 538146309.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Liveperson (LPSN)?

The current stock price of Liveperson (LPSN) is $2.69 as of March 12, 2026.

What is the market cap of Liveperson (LPSN)?

The market cap of Liveperson (LPSN) is approximately 32.3M.

LPSN Rankings

LPSN Stock Data

32.33M
10.51M
Software - Application
Services-prepackaged Software
Link
United States
NEW YORK

LPSN RSS Feed